HM03127 | CRIPT | bladder | MESH:D002292 | Carcinoma, Renal Cell | kidney |
HM03127 | CRIPT | bladder | MESH:D002278 | Carcinoma in Situ | |
HM03127 | CRIPT | bladder | MESH:D002278 | Carcinoma in Situ | |
HM03127 | CRIPT | bladder | MESH:D015179 | Colorectal Neoplasms | |
HM03127 | CRIPT | bladder | MESH:D014591 | Uterine Diseases | uterus |
HM03127 | CRIPT | bladder | MESH:D014591 | Uterine Diseases | placenta |
HM03127 | CRIPT | bladder | MESH:D014591 | Uterine Diseases | cervix |
HM03127 | CRIPT | bladder | MESH:D007333 | Insulin Resistance | |
HM03127 | CRIPT | bladder | MESH:D007249 | Inflammation | |
HM03127 | CRIPT | bladder | MESH:D002471 | Cell Transformation, Neoplastic | |
HM03127 | CRIPT | bladder | MESH:D011297 | Prenatal Exposure Delayed Effects | |
HM03127 | CRIPT | bladder | MESH:D006689 | Hodgkin Disease | |
HM03127 | CRIPT | bladder | MESH:D011471 | Prostatic Neoplasms | prostate |
HM03127 | CRIPT | bladder | MESH:D004938 | Esophageal Neoplasms | |
HM03127 | CRIPT | bladder | MESH:D001943 | Breast Neoplasms | breast |
HM03127 | CRIPT | bladder | MESH:D011629 | Puberty, Precocious | |
HM03127 | CRIPT | bladder | MESH:D019966 | Substance-Related Disorders | |
HM03127 | CRIPT | bladder | MESH:D005909 | Glioblastoma | bone |
HM03127 | CRIPT | bladder | MESH:D005909 | Glioblastoma | brain |
HM03127 | CRIPT | bladder | MESH:D005909 | Glioblastoma | bone |
HM03127 | CRIPT | bladder | MESH:D009421 | Nervous System Malformations | |
HM03127 | CRIPT | bladder | MESH:D009503 | Neutropenia | bone marrow |
HM03127 | CRIPT | bladder | MESH:D008545 | Melanoma | eye |
HM03127 | CRIPT | bladder | MESH:D008545 | Melanoma | cervix |
HM03127 | CRIPT | bladder | MESH:D008545 | Melanoma | bone |
HM03127 | CRIPT | bladder | MESH:D010049 | Ovarian Diseases | ovary |
HM03127 | CRIPT | bladder | MESH:D014625 | Vaginal Neoplasms | bone |
HM03127 | CRIPT | bladder | MESH:D014625 | Vaginal Neoplasms | |
HM03127 | CRIPT | bladder | MESH:D001862 | Bone Resorption | |